.
BioEnterprise

Cell Targeting

Cell Targeting (acquired by BioTime) is developing a family of novel homing peptides to enhance targeting of therapeutic cells to specific tissues or organs. The company’s technology has both clinical and research applications with a portfolio of 15 target organs and tissues.

Funding

Toucan Ventures, DARPA

Stage

Preclinical